Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
10/2006
10/19/2006US20060233704 Prochelator for the preparation of radiometal labeled molecules having improved biological properties
10/17/2006US7122676 Reacting oxalimidic acid dihydrazide with sodium nitrite
10/17/2006CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/11/2006EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/11/2006CN1844128A Process for synthesizing tetra-substituted amino macrocyclic metal complex
10/11/2006CN1844110A Method for synthesizing Valsartan with high optical purity
10/11/2006CN1279030C Complex of 3,6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and transition metal, its preparation and application
10/10/2006US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist
10/05/2006WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases
10/05/2006US20060223872 Insecticidal phthalamide derivatives
10/05/2006CA2600833A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/04/2006EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds
10/04/2006EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/03/2006US7115749 For inhibiting hepatitis c virus RNA-dependent polymerase
10/01/2006CA2541379A1 Losartan potassium crystalline form alpha
09/2006
09/28/2006WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006US20060217549 Diamine purification method
09/28/2006US20060217548 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, cyclene and functionalised cyclenes
09/27/2006EP1704150A1 2,3-dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/27/2006EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
09/27/2006CN1276922C Metal phthalocyanine derivative, salt and preparing method thereof
09/26/2006CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis
09/21/2006WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor
09/21/2006CA2597444A1 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use
09/20/2006CN1275917C Glucocorticoid receptor modulators
09/20/2006CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease
09/19/2006US7109223 neuroprotective effect; potent selective agonists of the EP4 subtype of prostaglandin E2 receptors
09/19/2006US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
09/19/2006US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role
09/14/2006WO2006095771A1 Complex compound and mri probe made of same
09/14/2006WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
09/13/2006EP1699466A2 New compounds useful as metal chelators
09/13/2006CN1832931A A process for the preparation of phenyltetrazole derivatives
09/13/2006CN1832742A Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/12/2006US7105557 Polymorphs of valsartan
09/08/2006WO2006093864A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use
09/08/2006WO2006023889A3 A method for preparing irbesartan and intermediates thereof
09/08/2006CA2597463A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use
09/07/2006US20060199826 Cyclopropane compounds and pharmaceutical use thereof
09/06/2006EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
09/06/2006EP1697292A1 Method for the production of tetrahydrogeranylacetone
09/06/2006CN1273455C Process for preparation of N-1 protected N ring nitrogen -containing cyclic polyamines and products thereof
09/06/2006CN1273448C Method for preparing aryl alkyl hydrogen peroxide
09/05/2006US7102011 Visualizing cellular organelles and cytoskeletons; obtain tissue sample, fix tissue, incubate with crystalizing agents, visualizing cellular organelles, visualize crystals formed in organelles detect numbers and shape of oganelle
09/05/2006US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/05/2006US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
09/05/2006US7101449 Method for recovery of nitramines from aluminized energetic materials
08/2006
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/30/2006EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006CN1826331A Pi-3 kinase inhibitor prodrugs
08/30/2006CN1826329A Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/29/2006US7098342 Dehydrohalogenation to form cilexetin trityl candesartan in the presence of phase transfer compounds
08/29/2006US7098212 Piperazine derivatives
08/29/2006CA2201785C New carboxylic acid derivatives, their preparation and their use
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/24/2006WO2006087135A1 Tetrazine derivatives having an antimycotic effect, and use thereof
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006DE102005007739A1 Tetrazinderivate mit antimykotischer Wirkung und ihre Verwendung Tetrazine derivatives with antifungal activity and their use
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/23/2006CN1823049A Water-soluble tetrazolium compounds
08/23/2006CN1271068C Novel method for preparing olmesartan
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/17/2006WO2006085510A1 Remedy for irritable bowel syndrome
08/17/2006WO2006085111A1 Anthranilic acid derivatives active at the hm74a receptor
08/17/2006WO2006067216A3 Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
08/17/2006US20060183916 By direct ortho-metallation of (tetrazol-5- gamma l)benzene; useful intermediates for the preparation of angiotensin II antagonists used, for example, in the treatment of hypertension, anxiety, glaucoma and heart failure; provides high yields, is less costly than known procedures
08/16/2006EP1690857A1 Modified-protein formation inhibitor
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1819997A Synthesis of tris n-alkylated 1,4,7,10-tetraazacyclododecanes
08/16/2006CN1269819C Synthesis of temozolomide and analogs
08/15/2006US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation
08/15/2006US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/10/2006WO2006081807A2 Method for the production of losartan
08/10/2006US20060178413 Diphenylurea derivatives and their use as chloride channel blockers
08/10/2006CA2595962A1 Method for the production of losartan
08/09/2006EP1687258A2 Vitamin d receptor modulators
08/09/2006CN1816533A Pharmaceutical composition comprising valsartan
08/09/2006CN1268625C Cyclic amp-specific phosphodiesterase inhibitors
08/09/2006CN1268615C Substituted benzoylcyclohexenones
08/09/2006CN1268610C Sulfonamide derivatives
08/08/2006US7087631 Aryltetrazole compounds, and compositions thereof
08/08/2006CA2188835C Novel compounds and methods for synthesis and therapy
08/03/2006WO2006079610A1 Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/02/2006EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline
08/02/2006EP1684694A2 Akt protein kinase inhibitors
08/02/2006EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/02/2006CN1812967A Cathepsin cysteine protease inhibitors
07/2006
07/27/2006WO2005051304A3 Akt protein kinase inhibitors
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166859 Compounds and compositions for delivering active agents
07/27/2006US20060165600 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 97